Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases

Molecular Immunology

Volumn 47, Issue 11-12, 2010, Pages 2065-2073

  Mitchell, Daniel ^a   Olive, Colleen ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Cell signaling; Immune modulation; Inflammatory response; Innate immunity; MAPKs; Toll like receptors

Indexed keywords

CD135 ANTIGEN; CHEMOKINE; CPG OLIGODEOXYNUCLEOTIDE; I KAPPA B; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; RESIQUIMOD; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; VACCINE;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW CELL; CELL CULTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPERNATANT; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CHEMOKINE CCL2; CHEMOKINES; DENDRITIC CELLS; FEMALE; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; TOLL-LIKE RECEPTORS;

MURINAE;

EID: 77953616751     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.04.004     Document Type: Article

References (40)

1. Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 2006, 311:17-58.
2. Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 2004, 199:227-250.
3. Kawai T., Akira S. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 2005, 17:338-344.
4. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Revs. Immunol. 2007, 7:179-190.
5. Hemmi H., Akira S. TLR signaling and the function of dendritic cells. Chem. Immunol. Allergy 2005, 86:120-135.
6. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
7. Napolitani G., Rinaldi A., Bertoni F., Sallustro F., Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 2005, 6:769-776.
8. Roelofs M.F., Joosten L.A.B., Abdollahi-Roodsaz S. The expression of Toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of Toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 2005, 52:2313-2322.
9. Warger T., Osterloh P., Rechtsteiner G., et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses. Blood 2009, 108:544-550.
10. Vanhoutte F., Paget C., Breuilh L., Fontaine J., Vendeville C., Goriely S., Ryffel B., Faveeuw C., Trottein F. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells. Immunol. Lett. 2008, 116:86-94.
11. Bagchi A., Herrup E.A., Warren H.S., Trigilio J., Shin H.-S., Valentine C., Hellman J. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 2007, 178:1164-1171.
12. Zhu Q., Egelston C., Vivekanandham A., Uematsu S., Akira S., Klinman D.M., Belyakov I.M., Berzofsky J.A. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16260-16265.
13. Hirata N., Yanagawa Y., Ebihara T., Seya T., Uematsu S., Akira S., Hayashi F., Iwabuchi K., Onoe K. Selective synergy in anti-inflammatory cytokine production upon cooperated signalling via TLR4 and TLR2 in murine conventional dendritic cells. Mol. Immunol. 2008, 45:2734-2742.
14. Bohnenkamp H.R., Papazisis K.T., Burchell J.M., Taylor-Papadimitriou J. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type I responses. Cell Immunol. 2007, 247:72-84.
15. Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E.E.M., Trinchieri G., Caux C., Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 2005, 210:1435-1446.
16. De Jong E.C., Smits H.H., Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunol. 2005, 26:289-307.
17. + T cells. J. Leukoc. Biol. 2009, 86:1427-1437.
18. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 2009, 9:556-557.
19. van Duin D., Medzhitov R., Shaw A.C. Triggering TLR signalling in vaccination. Trends Immunol. 2006, 27:49-55.
20. Dillon S., Agrawal A., Van Dyke T., Landreth G., McCauley L., Koh A., Maliszewski C., Akira S., Pulendran B. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-related kinase mitogen-activated protein kinase and c-fos in dendritic cells. J. Immunol. 2004, 172:4733-4743.
21. Redecke V., Hacker H., Datta S.K., Fermin A., Pitha P.M., Broide D.H., Raz E. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 2004, 172:2739-2743.
22. Didierlaurent A., Ferrero I., Otten L.A., Dubois B., Reinhardt M., Carlsen H., Bomhoff R., Akira Kraehenbuhl J.-P., Sirard J.-C. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J. Immunol. 2004, 172:6922-6930.
23. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006, 354:610-621.
24. Omata N., Yasutomi M., Yamada A., Iwasaki H., Mayumi M., Ohshima Y. Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 responses. J. Immunol. 2002, 169:4861-4866.
25. Karpus W., Kennedy K.J., Kunkel S.L., Lukacs N.W. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. Exp. Med. 1998, 187:733-741.
26. Chensue S.W., Warmington K.S., Ruth J.H., Sanghi P., Lincoln P., Kunkel S.L. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (Mycobacterial) and Th2 (Schistosomal) antigen-induced granuloma formation. J. Immunol. 1996, 157:4602-4608.
27. Gu L., Tseng S., Horner R.M., Tam C., Loda M., Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000, 404:407-411.
28. Del Corno M., Michienzi A., Masotti A., Da Sacco L., Bottazzo G.F., Belardelli F., Gessani S. CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper polarization in human dendritic cells. Blood 2009, 114:796-806.
29. Hazeki K., Nigorikawa K., Hazeki O. Role of phosphoinositide 3-kinase in innate immunity. Biol. Pharm. Bull. 2007, 30:1617-1623.
30. Fukao T., Tanabe M., Terauchi Y., Ota T., Matsuda S., Asano T., Kadowaki T., Takeuchi T., Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 2002, 3:875-881.
31. Lu Y., Xin K.-Q., Hamajima K., Tsuji T., Aoki I., Yang J., Sasaki S., Fukushima J., et al. Macrophage inflammatory protein-1α (MIP-1α) expression plasmid enhances DNA vaccine-induced immune response against HIV-1. Clin. Exp. Immunol. 1999, 115:335-341.
32. Song R., Liu S., Leong K.W. Effects of MIP-1α, MIP-3α and MIP-3β on the induction of HIV Gag-specific immune response with DNA vaccines. Mol. Ther. 2007, 15:1007-1015.
33. Yoon H.A., Kug Eo S. Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus. Immunology 2006, 120:182-191.
34. Dowling D., Hamilton C.M., O'Neill S.M. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 2008, 41:254-262.
35. Dearman R.J., Cumberbatch M., Maxwell G., Basketter D.A., Kimber I. Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells. Immunology 2008, 126:475-484.
36. Mitchell, D., Yong, M., Schroder, W., Black, M., Tirrell, M., Olive, C., 2010. Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells. J. Infect. Dis.
37. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated proten kinase and c-fos. J. Immunol. 2003, 171:4984-4989.
38. Jarnicki A.G., Conroy H., Brereton C., Donnelly G., Toomey D., Walsh K., Sweeney C., Leavy O., Fletcher J., Lavelle E.C., Dunne P., Mills K.H. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J. Immunol. 2008, 180:3797-3806.
39. Yanagawa Y., Onoe K. Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation. J. Immunol. 2007, 178:6173-6180.
40. Bernatoniene J., Zhang Q., Dogan S., Mitchell T.J., Paton J.C., Finn A. Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by Toll-like receptor 4, NF-kB, and mitogen-activated protein kinases. J. Infect. Dis. 2008, 198:1823-1833.